Table 3.
Participants’ descriptive information in using the VRDS.
| Participant | Condition | Total number of trials | Number of trials-Level 1 | Number of trials-Level 2 | Number of trials-Level 3 |
|---|---|---|---|---|---|
| 1 | Healthy | 26 | 6 | 8 | 12 |
| 2 | Healthy | 23 | 4 | 7 | 12 |
| 3 | MCI | 20 | 4 | 9 | 7 |
| 4 | MCI | 21 | 9 | 8 | 4 |
| 5 | MCI | 26 | 5 | 13 | 8 |
| 6 | MCI | 43 | 12 | 21 | 10 |
| 7 | AD | 27 | 14 | 11 | 2 |
| 8 | AD | 26 | 12 | 14 | 0 |
| 9 | AD | 17 | 8 | 7 | 2 |
| 10 | AD | 24 | 12 | 12 | 0 |
| Mean ± stdev. | 25.3 ± 7.0 | 8.6 ± 3.7 | 11 ± 4.3 | 5.7 ± 4.7 | |
| 11 | Advanced AD | 19 | 17 | 2 | 0 |
Abbreviations: MCI, Mild Cognitive Impairment; AD, Alzheimer’s disease.